Literature DB >> 23760240

Capsid antibodies to different adeno-associated virus serotypes bind common regions.

Brittney L Gurda1, Michael A DiMattia, Edward B Miller, Antonette Bennett, Robert McKenna, Wendy S Weichert, Christian D Nelson, Wei-jun Chen, Nicholas Muzyczka, Norman H Olson, Robert S Sinkovits, John A Chiorini, Sergei Zolotutkhin, Olga G Kozyreva, R Jude Samulski, Timothy S Baker, Colin R Parrish, Mavis Agbandje-McKenna.   

Abstract

Interactions between viruses and the host antibody immune response are critical in the development and control of disease, and antibodies are also known to interfere with the efficacy of viral vector-based gene delivery. The adeno-associated viruses (AAVs) being developed as vectors for corrective human gene delivery have shown promise in clinical trials, but preexisting antibodies are detrimental to successful outcomes. However, the antigenic epitopes on AAV capsids remain poorly characterized. Cryo-electron microscopy and three-dimensional image reconstruction were used to define the locations of epitopes to which monoclonal fragment antibodies (Fabs) against AAV1, AAV2, AAV5, and AAV6 bind. Pseudoatomic modeling showed that, in each serotype, Fabs bound to a limited number of sites near the protrusions surrounding the 3-fold axes of the T=1 icosahedral capsids. For the closely related AAV1 and AAV6, a common Fab exhibited substoichiometric binding, with one Fab bound, on average, between two of the three protrusions as a consequence of steric crowding. The other AAV Fabs saturated the capsid and bound to the walls of all 60 protrusions, with the footprint for the AAV5 antibody extending toward the 5-fold axis. The angle of incidence for each bound Fab on the AAVs varied and resulted in significant differences in how much of each viral capsid surface was occluded beyond the Fab footprints. The AAV-antibody interactions showed a common set of footprints that overlapped some known receptor-binding sites and transduction determinants, thus suggesting potential mechanisms for virus neutralization by the antibodies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760240      PMCID: PMC3754064          DOI: 10.1128/JVI.00622-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  101 in total

1.  Multi-resolution contour-based fitting of macromolecular structures.

Authors:  Pablo Chacón; Willy Wriggers
Journal:  J Mol Biol       Date:  2002-03-29       Impact factor: 5.469

2.  Structure of adeno-associated virus serotype 8, a gene therapy vector.

Authors:  Hyun-Joo Nam; Michael Douglas Lane; Eric Padron; Brittney Gurda; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Barry Byrne; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

3.  Modeling antibody hypervariable loops: a combined algorithm.

Authors:  A C Martin; J C Cheetham; A R Rees
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6).

Authors:  Qing Xie; Thomas F Lerch; Nancy L Meyer; Michael S Chapman
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

5.  Subcellular compartmentalization of adeno-associated virus type 2 assembly.

Authors:  A Wistuba; A Kern; S Weger; D Grimm; J A Kleinschmidt
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

Authors:  E A Rutledge; C L Halbert; D W Russell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen.

Authors:  Cory L Brooks; Ryan J Blackler; Georg Sixta; Paul Kosma; Sven Müller-Loennies; Lore Brade; Tomoko Hirama; C Roger MacKenzie; Helmut Brade; Stephen V Evans
Journal:  Glycobiology       Date:  2009-09-18       Impact factor: 4.313

9.  A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus.

Authors:  Szilvia L Farkas; Zoltán Zádori; Mária Benkő; Sandra Essbauer; Balázs Harrach; Peter Tijssen
Journal:  J Gen Virol       Date:  2004-03       Impact factor: 3.891

10.  A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer.

Authors:  Hua Li; Shih-Wen Lin; Wynetta Giles-Davis; Yan Li; Dongming Zhou; Zhi Quan Xiang; Katherine A High; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

View more
  66 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  Mapping Antigenic Epitopes on the Human Bocavirus Capsid.

Authors:  Shweta Kailasan; Jamie Garrison; Maria Ilyas; Paul Chipman; Robert McKenna; Kalle Kantola; Maria Söderlund-Venermo; Indrė Kučinskaitė-Kodzė; Aurelija Žvirblienė; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

3.  Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2.

Authors:  Antonette Bennett; Annahita Keravala; Victoria Makal; Justin Kurian; Brahim Belbellaa; Rangoli Aeran; Yu-Shan Tseng; Duncan Sousa; John Spear; Mehdi Gasmi; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2019-12-16       Impact factor: 2.867

4.  Modulation of Sialic Acid Dependence Influences the Central Nervous System Transduction Profile of Adeno-associated Viruses.

Authors:  Blake H Albright; Katherine E Simon; Minakshi Pillai; Garth W Devlin; Aravind Asokan
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 5.  Adeno-associated virus: fit to serve.

Authors:  Eric Zinn; Luk H Vandenberghe
Journal:  Curr Opin Virol       Date:  2014-08-13       Impact factor: 7.090

6.  Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.

Authors:  Zheng Chai; Junjiang Sun; Kelly Michelle Rigsbee; Mei Wang; R Jude Samulski; Chengwen Li
Journal:  J Control Release       Date:  2017-08-05       Impact factor: 9.776

7.  Primate optogenetics: Progress and prognosis.

Authors:  Yasmine El-Shamayleh; Gregory D Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

Review 8.  Adeno-associated virus as a gene therapy vector: strategies to neutralize the neutralizing antibodies.

Authors:  Majid Lotfinia; Meghdad Abdollahpour-Alitappeh; Behzad Hatami; Mohammad Reza Zali; Morteza Karimipoor
Journal:  Clin Exp Med       Date:  2019-05-03       Impact factor: 3.984

9.  Cryo-electron Microscopy Reconstruction and Stability Studies of the Wild Type and the R432A Variant of Adeno-associated Virus Type 2 Reveal that Capsid Structural Stability Is a Major Factor in Genome Packaging.

Authors:  Lauren M Drouin; Bridget Lins; Maria Janssen; Antonette Bennett; Paul Chipman; Robert McKenna; Weijun Chen; Nicholas Muzyczka; Giovanni Cardone; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Development of Patient-specific AAV Vectors After Neutralizing Antibody Selection for Enhanced Muscle Gene Transfer.

Authors:  Chengwen Li; Shuqing Wu; Blake Albright; Matthew Hirsch; Wuping Li; Yu-Shan Tseng; Mavis Agbandje-McKenna; Scott McPhee; Aravind Asokan; R Jude Samulski
Journal:  Mol Ther       Date:  2015-07-29       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.